High-Dimensional Data and Machine Learning for SaMD (Software as a Medical Device)
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Shift Toward Algorithmic Validation The integration of machine learning (ML) into Software as a Medical Device (SaMD), has fundamentally altered the regulatory landscape. The industry’s transition from the use of traditional statistical modeling (SM) to machine learning (ML) within device technology, has necessitated a paradigm shift in how predictive algorithms are validated. Under the EU Medical Device…
Can AI Automate a SAP?
Beneath the Surface of the Statistical Analysis Plan There is an emerging commercial narrative that AI can automate the drafting of a Statistical Analysis Plan (SAP) directly from a clinical protocol. Extract the endpoints, populate a template, link to table shells, and the plan is ready. For anyone who has lived through the hours behind the process of drafting a SAP, the appeal is immediate. The promise of a…
Variance Components and Mixed Models in Multi-Site Medical Device Studies
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Complexity of Device Variability Under ISO 13485:2016 and MDR 2017/745 in the EU, medical device manufacturers must carefully control and validate their product manufacturing processes. A critical aspect of this validation is quantifying the sources of variability in the device's Critical Quality Attributes (CQAs). While pharmaceutical manufacturing controls unit-to-unit variation through content-uniformity and dissolution testing, inherent variability in…
Bayesian Adaptive Designs for Medical Device Clinical Investigations
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Statistical Advantage of Iterative Medical Device Development Medical devices are iterative, physical, and engineerable. By the time a medical device reaches a pivotal clinical investigation, it has undergone extensive Verification and Validation (V&V) bench testing, biocompatibility assessments, and often animal studies. The physics of the device (such as its tensile strength, fatigue life, thermal dissipation, or sensor accuracy)…
Sample Size Justification in the Era of MDR: Navigating Power, Tolerance, and Assurance
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Rejection of "Industry Standard" Sample Size A frequently cited Major Non-Conformity in Notified Body audit reports under the EU Medical Device Regulation (MDR 2017/745) and IVDR 2017/746 is the inadequate statistical justification of sample size estimates. During design control reviews and Clinical Evaluation Report (CER) appraisals, technical reviewers consistently reject sample size rationale predicated on "historical precedent"…
Equivalence and Non-Inferiority Margins in 510(k) and CE Mark Submissions
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Trap of "Substantial Equivalence" Regulatory pathways for medical devices rely heavily on the concept of equivalence. Under the US FDA 510(k) framework, a manufacturer must demonstrate that a new device is "substantially equivalent" to a legally marketed predicate. In Europe, the EU Medical Device Regulation (MDR 2017/745) Article 61 requires clinical evaluation data to demonstrate equivalent safety…
Beyond OLS: Passing-Bablok & Deming Regression Advanced Methods for In-Vitro Diagnostics Under CLSI EP09 and IVDR
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Demand for Statistical Rigour in IVDs During the late stages of a technical file, method comparison is sometimes presented as a simple scatter plot with a standard trendline. The accompanying correlation coefficient is usually high, offering a false sense of security that the new diagnostic device matches the reference method perfectly. This approach masks a significant statistical…
The Clinical Evaluation Gap: Why Standard Biostatistics Curricula Fall Short in MedTech
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering Medical Device Biostatistics: Navigating EU MDR, IVDR, and Commercial Lifecycle Challenges The transition from academic biostatistics to the medical device industry often highlights a profound gap in methodological fit. Conventional statistical training often draws heavily from public health and academic clinical trial paradigms, focusing on large-scale randomised controlled trials and complex survival analyses. This framework is optimised for evaluating…
A (Non-Technical) Guide to the Statistical Analysis Plan in MedTech Industry Clinical Trials: Design, Review, and Operational Reality
Introduction Under the EU Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), the scrutiny applied to clinical evidence has fundamentally shifted. Notified Bodies and the UK MHRA are no longer simply checking for the existence of clinical data; they are interrogating the methodological soundness of how that data is generated, analysed, and interpreted. At the centre of this regulatory attention is the Statistical Analysis Plan (SAP).…